MS

Mohammad Salman

Active Director Director DIN 10092443
DIN 10092443 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Mohammad Salman

Data last updated:

Mohammad Salman is a Director at Ochron Pharma Private Limited (since 2023). The company operates in Pharma. Ochron Pharma Private Limited reported revenue of ₹1.36 Cr (FY 2025).

DIN 10092443
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 2023
Oldest Company Age 3 yrs
Largest company Ochron Pharma Private Limited · ₹1.36 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ochron Pharma Private Limited U46909UP2023PTC179114
Director28 Mar 20232023₹1.36 Cr (FY 2025)Active

Board colleagues of Mohammad Salman

Directorship timeline

Open interactive timeline →
Ochron Pharma Private Limited
Premium access

Shareholding and investment profile for Mohammad Salman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Salman

Mohammad Salman currently holds 1 directorship: Ochron Pharma Private Limited (Director, since 28 Mar 2023, revenue ₹1.36 Cr (FY 2025)).

Mohammad Salman was first appointed on 28 Mar 2023 as Director at Ochron Pharma Private Limited.

The current boards of Mohammad Salman's companies include Mohammad Farhan (Ochron Pharma Private Limited), Mohammad Shahan (Ochron Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available